Aliskiren improves nitric oxide bioavailability and limits atherosclerosis.
Verma
Subodh
S
Gupta
Milan K
MK
D000577:Amides / Q000627:therapeutic use*; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control; D005650:Fumarates / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism*
D000577:Amides; D000959:Antihypertensive Agents; D005650:Fumarates; D009569:Nitric Oxide; C446481:aliskiren